The end of the road for the campaign against MMR.

The end of the road for the campaign against MMR. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The end of the road for the campaign against MMR. Abstract Text:

Mike Fitzpatrick,

The end of the road for the campaign against MMR. Publishing Authors By Initials

M Fitzpatrick,

For similar therapeutics: biological therapy: immunotherapy: immunization: immunotherapy, active: vaccination research abstracts see: therapeutics: biological therapy: immunotherapy: immunization: immunotherapy, active: vaccination research

PUBMED ID PMID:

MEDLINE DATE:

The end of the road for the campaign against MMR. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: The British journal of general practice : the jour

VOLUME: 57

Page Numbers: 679

Journal Abbreviation:

ISSN: 0960-1643

DAY: 28

MONTH: Aug

YEAR: 2007

The end of the road for the campaign against MMR. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9005323

The end of the road for the campaign against MMR. Keywords Mesh Terms:

KEYWORDS: Vaccination

MESH TERMS: legislation & jurisprudence

Chemical & Substance for Abstract: The end of the road for the campaign against MMR. Information

Substance Name: Thimerosal

Registry Number: 54-64-8

Grant and Affiliation Information for The end of the road for the campaign against MMR.

AFFILIATION:

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Br J Gen Pract

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The end of the road for the campaign against MMR Related Publications

• A grim future foretold.
• Akt activation by arachidonic acid metabolism occurs via oxidation and inactivation of PTEN tumor suppressor.
• Behavioral sensitivity to interaural time differences in the rabbit.
• Bereavement among faculty members in a university setting.
• Connections of functional areas in the mustached bat's auditory cortex with the auditory thalamus.
• Cortical cartography revisited: A frequency perspective on the functional architecture of visual cortex.
• Detection of simultaneous movement at two human arm joints.
• Development of the Oxford ankle foot questionnaire: finding out how children are affected by foot and ankle problems.
• Direct spectroscopic evidence for a high-spin Fe(IV) intermediate in tyrosine hydroxylase.
• Endogenous growth factors as cosmeceuticals.
• Global theme issue on poverty and human development.
• ISI Web of Knowledge:New Author Searching Capability and Reports Features.
• Keeping your cool while changing your job.
• Laser resurfacing today and the "cookbook" approach: a recipe for disaster? A comment.
• Levels of autonomy of nurse practitioners in an acute care setting.
• Luminance-evoked inhibition in primary visual cortex: a transient veto of simultaneous and ongoing response.
• Mechanistic and structural studies of H373Q flavocytochrome b2: effects of mutating the active site base.
• Mechanistic studies of the flavoenzyme tryptophan 2-monooxygenase: deuterium and 15N kinetic isotope effects on alanine oxidation by an L-amino acid oxidase.
• Neural and behavioral sensitivity to interaural time differences using amplitude modulated tones with mismatched carrier frequencies.
• Oxidation of 2-Cys-peroxiredoxins by arachidonic acid peroxide metabolites of lipoxygenases and cyclooxygenase-2.
• Physiological and metabolic effects of prophylactic treatment with the osmolytes glycerol and betaine on Bos indicus steers during long duration transportation.
• Posttraumatic stress disorder and posttraumatic stress disorder-like symptoms and mild traumatic brain injury.
• Safety and acceptability of implantation of internal cardioverter-defibrillators under local anesthetic and conscious sedation.
• Socioeconomic status, psychosocial health and health behaviours among Hungarian adolescents.
• The end of the road for the campaign against MMR.
• The gender conundrum.
• The reciprocal relationship between melanization and tyrosinase activity in melanosomes (melanin granules).
• Two-Year Treatment With Denosumab (AMG 162) in a Randomized Phase 2 Study of Postmenopausal Women With Low BMD.
• Vision and cortical map development.
• Vitamin B1 biosynthesis in plants requires the essential iron sulfur cluster protein, THIC.